Tag Archive for PRO/AH/EDR> COVID-19 update (371): remdesivir vs standard care, countries, WHO, global
PRO/AH/EDR> COVID-19 update (371): remdesivir vs standard care, countries, WHO, global
COVID-19 -- Worldwide/UnknownImportance: Remdesivir demonstrated clinical benefit in a placebo-controlled trial in patients with severe coronavirus disease 2019 (COVID-19), but its effect in patients with moderate disease is unknown.Objective: To determine the efficacy of 5 or 10 days of remdesivir treatment compared with standard care on clinical status on day 11 after initiation of treatment.Design, Setting, and Participants: Randomized, open-label trial of hospitalized patients with confirmed Read more [...]
